Federal obligations in physical, engineering, and life sciences R&D except biotechnology (NAICS 541712)

Where 541712 sits among R&D NAICS codes

NAICS 541712 is R&D in the physical, engineering, and life sciences except biotechnology. USAspending.gov still shows contract awards with this code because agencies used it on vehicles that remain in the file, including modifications. It is not the same row as 541710 (the combined code with no except clause) and not the same row as 541715 (which excepts both nanotechnology and biotechnology). Biotech R&D belongs on 541711 or 541714.

The $145.6 billion total is smaller than 541710 and 541715 in this dataset, and the 8,022 award count sits between 541710’s few hundred records and 541715’s tens of thousands. That middle pattern is a reason to keep the codes on separate pages. Adding 541712 to 541715 as “all physical sciences R&D” will double-count work that was retagged over time or mix two manuals.

Obligations of $145.6 billion

USAspending reports obligations, the committed amounts on contract awards tagged 541712. Task orders, incremental funding, and modifications all feed $145,644,197,179.80. This packet has no fiscal-year split and no outlay total. A research contract can show a large obligation while invoices are still being paid.

Quote the figure as USAspending contract obligations coded to NAICS 541712. Do not describe it as the federal R&D budget, as grant spending, or as cash already disbursed. Those are different public-record fields.

8,022 awards, not 8,022 laboratories

The 8,022 award records include orders and modifications coded to this except-biotechnology R&D line. The count is not a census of labs or of principal investigators. It is a thinner record set than high-volume professional-services codes and a thicker set than the oldest combined R&D line. Use the industry table to see concentration among recipients.

Vintage R&D codes are a filing problem disguised as a science problem. NAICS 541712 is physical, engineering, and life sciences R&D except biotechnology: $145,644,197,179.80 in USAspending obligations on 8,022 awards. 541710 is the combined ancestor. 541715 is the later split that also excepts nanotechnology. Biotech lines are 541711 and 541714. This page has only 541712 facts. Retags among those codes move dollars without moving laboratories. The 8,022 records are contract actions, not labs. Grants often have no NAICS. Cite the except-biotechnology qualifier. Cite obligations, not outlays. Cite USAspending.gov. The industry page is current; this guide restates the packet.

Grants and other exclusions

Assistance awards often lack NAICS and are outside $145,644,197,179.80. Social-science R&D is 541720. Engineering services (541330) is not this R&D code. Manufacturing of products that research may later yield sits on production NAICS lines.

SpendingVault aggregates USAspending.gov contract data. The dollar total and the 8,022 award count can move after corrections. The live industry page is the working table.

Using the 541712 industry page

Open the RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) industry page for the award list. Keep 541712 distinct from 541710 and 541715 on All industries. Cite USAspending, say obligations not outlays, and keep the except-biotechnology qualifier in the name.

Citing 541712 as a vintage except-biotech line

Cite $145,644,197,179.80 in USAspending contract obligations on 8,022 awards tagged NAICS 541712, physical, engineering, and life sciences R&D except biotechnology. Keep except biotechnology in the name so the figure is not read as all life-sciences work.

Do not add 541715 or 541710 dollars to this total. Those pages have their own facts. The 8,022 award count is this packet’s volume signal only. Grants remain outside when they lack NAICS. Quote obligations, not outlays, and use the industry table for award-level detail.

Think of 541712 as a middle vintage: newer than the combined 541710 label, older than the 541715 label that also excepts nanotechnology. The $145,644,197,179.80 total and the 8,022 awards belong only to awards that still carry 541712. Retags onto 541715 move dollars off this page. Retags the other way move dollars on. This guide cannot see those movements after the packet was harvested.

Except biotechnology is the boundary with 541711 and 541714. Life-sciences work that an officer still considers non-biotech can sit here; work they consider biotech should not. That judgment lives on the award file, not in this narrative. Cite USAspending, obligations, 8,022 awards, and the except-biotechnology qualifier.

Questions

How much is obligated on NAICS 541712?

USAspending.gov contract awards coded NAICS 541712 show $145,644,197,179.80 in obligations across 8,022 awards. That total is obligations, not outlays, for physical, engineering, and life sciences R&D except biotechnology. USAspending.gov records the amount as contract obligations, not outlays, on awards tagged NAICS 541712.

How does 541712 differ from 541715?

541712 excepts biotechnology. 541715 excepts nanotechnology and biotechnology and shows a different award count on its own industry page. This page reports only $145,644,197,179.80 on 541712. Do not merge the codes. The packet total is $145,644,197,179.80 across 8,022 awards; assistance awards often have no NAICS and stay outside the industry rollup.

Is biotechnology R&D in this total?

The NAICS title excepts biotechnology. Biotech R&D belongs on 541711 or 541714. Dollars here are the $145,644,197,179.80 tagged 541712. Treat the 8,022 figure as an award-record count, including orders and modifications, not as a physical inventory of products or sites.

Are university research grants included?

Assistance awards may not carry NAICS and are generally outside this industry total. The 8,022 awards are contract records tagged 541712, not a grant inventory. This guide does not add a fiscal-year split. Quote the live industry page if you need the current award list under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY).